Latest News and News Archives
Call for Presentation Proposals and Posters for the Spring Seminar, April 8-10, Kalahari Resort, Spotsylvania
VSHP is accepting speaker proposals that will provide quality continuing education to our members. Please see deadlines below.
Thank you for supporting the educational mission of VSHP!
The 2027 Spring Hot Topics list is located below. The VSHP Education Committee will consider all topics for presentation, with additional consideration for all presentations related to subjects on the Hot Topics list. Presentations with interactive activities are encouraged. Pharmacists, residents and technicians are encouraged to submit.
Here is the link for the Presentation/Pearl proposals -- https://docs.google.com/forms/d/e/1FAIpQLSfOrw-yQSJa7wzjA97pM_n_1MXb_EDH9TzEcfSlRQBrSEWiQw/viewform?usp=publish-editor
Here is the link for the Poster proposals -- https://docs.google.com/forms/d/e/1FAIpQLScIbf2s5jPbvFxJDYV34X0fm9bcql4JdV_v9PBTccef1vju8A/viewform?usp=publish-editor
Hot topics
Hot topics with an administrative or leadership focus
VSHP and the Virginia Pharmacy Association (VPhA) are working together to plan the 2027 Pharmacy Legislative Day, bringing pharmacy professionals together to advocate for our profession and the patients we serve.
Join your pharmacy colleagues in Richmond on January 20 to help strengthen pharmacy’s voice in Virginia. Registration for VSHP and VPhA members is $25.
Event Details
Date: Wednesday, January 20, 2027 Time: 7:00 a.m.–3:00 p.m. Staging Location: VCU Biotech Center 800 E Leigh Street Richmond, VA 23298
Registration is open November 16, 2026–January 8, 2027, or until capacity is reached.
How to Register
For registration assistance, please contact the VPhA Office at jyork@virginiapharmacists.org.
We look forward to a strong VSHP presence as we come together to advance pharmacy in Virginia!
Josh Crawford & Nik Lawson
VSHP Webinar
November 12, 2026 – 12:00pm-1:00 pm
Wake-Up Call: Amantadine vs Modafinil in the Neurocritical Care Patient
Speaker:
Savannah Kangas, Pharm.D.
PGY1 Resident Pharmacist
Chippenham & Johnston-Willis Hospitals
Objectives for Pharmacists
At the completion of this activity, the participant will be able to:
Objectives for Pharmacy Technicians
At the conclusion of this activity, pharmacy technicians should be able to:
Accreditation:
Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit submitted to CPE Monitor as early as 1 day after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days. Participants must participate in the activity and complete the course evaluation in its entirety to claim continuing pharmacy education credit.
ACPE UAN: 0108-0000-26-056-L01-P; 0108-0000-26-056-L01-T
Activity type: Application-based
This is a member service of VSHP. There is no charge for members to attend. Dues must be current to receive CE credit.
Non-members will be charged $20.
To register: https://vshp.org/event-6885725
October 29, 2026 – 12:00pm-1:00 pm
Acute Pulmonary Embolism: What’s New and What It Means for Practice
Jacqueline Ashby, PharmD
ACPE UAN: 0108-0000-26-050-L01-P; 0108-0000-26-050-L01-T
To register: https://vshp.org/event-6867233
Thursday, August 20, 2026 – 12:00pm-1:00 pm
HIV for the Inpatient Pharmacist
Kristen Lindauer, Pharm.D., BCPS, AAHIVP
Clinical Pharmacy Specialist - Infectious Diseases/HIV
Sentara Norfolk General Hospital
ACPE UAN: 0108-0000-26-047-L02-P; 0108-0000-26-047-L02-T
To register: https://us06web.zoom.us/webinar/register/WN_tER64-ljSei4zzOuOsMNtg
Recording Available
Thursday, June 25, 2026 – 12:00pm-1:00 pm
Lipid-ly Evolving: What’s New for the 2026 Dyslipidemia Guidelines
Amanda Murray, PharmDPGY2 Ambulatory Care Resident
VCU School of Pharmacy
Describe key updates in cardiovascular risk assessment from the 2026 ACC/AHA Multisocietal Guidelines on the Management of Dyslipidemia.
Summarize pharmacologic treatment approaches and therapeutic goals used for primary and secondary prevention of cardiovascular disease.
Identify patient and treatment factors that influence guideline-directed dyslipidemia management and cardiovascular risk reduction strategies.
ACPE UAN: 0108-0000-26-045-L01-P; 0108-0000-26-045-L01-T
To register: https://us06web.zoom.us/webinar/register/WN_UlhnS477RTePvmKFOqtO0Q
Thursday, June 18, 2026 – 12:00pm-1:00 pm
Management of Psychotropic Medication Adverse Events
Jennifer Jacobson, PharmD
PGY1 Pharmacy Resident
Chesapeake Regional Medical Center (CRMC)
Chesapeake, VA
Recognize common adverse events associated with psychotropic medications and identify patient factors that may increase the risk of these medication-related complications.
Describe strategies used to prevent and manage psychotropic medication-related adverse events, including the role of medication monitoring, patient education, and interdisciplinary communication.
Identify pharmacologic and nonpharmacologic approaches used to address psychotropic medication-related adverse events and understand the pharmacy technician's role in supporting safe medication use.
ACPE UAN: 0108-0000-26-046-L01-P; 0108-0000-26-046-L01-T
To register: https://us06web.zoom.us/webinar/register/WN_xgm9z26wQLCNsIu72h6VWQ
Thursday, May 28, 2026 – 12:00pm-1:00 pm
To Hold or Not to Hold: Updates in Periprocedural Anticoagulation
Trevor Shaffer, PharmD
PGY1 Pharmacy Practice Resident
Winchester Medical Center
Identify common anticoagulants (e.g., warfarin, DOACs, heparins) and their key characteristics that influence
peri-operative management (e.g., half-life, route, monitoring needs).
Recognize types of surgical and procedural scenarios that may require adjustments to anticoagulation therapy.
Describe general timing considerations for holding and restarting different anticoagulants based on procedure
risk and medication characteristics.
Explain factors that impact peri-operative anticoagulation decisions, including bleeding risk, renal function, and
indication for therapy.
ACPE UAN: 0108-0000-26-044-L01-P; 0108-0000-26-044-L01-T
To register: https://us06web.zoom.us/webinar/register/WN_T8YCKyjfQzu1WG0XrhURmg
Tuesday, May 26, 2026 – 3:00pm-4:00 pm
When BiTE Therapy Bites Back: Toxicities of Bispecific Antibody Therapies
Morgan Chatterley PharmD
CJW Medical Center
1. Describe the pathophysiology and risk factors associated with bispecific therapy (BiTE) toxicities including
cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).
2. List clinical signs, symptoms, and grading criteria used to recognize these toxicities.
3. Recite prophylactic strategies to prevent CRS with specific BiTE therapies.
ACPE UAN: 0108-0000-26-034-L01-P; 0108-0000-26-034-L01-T
To register: https://us06web.zoom.us/webinar/register/WN_gV_r1oMeRea79t1goTzgPw
Thursday, May 7, 2026 – 12:00pm-1:00 pm
A Review of Cystic Fibrosis Modulator Therapies
Kirstin Wade, PharmD, MBA
ACPE UAN: 0108-0000-26-043-L01-P; 0108-0000-26-043-L01-T
To register: https://us06web.zoom.us/webinar/register/WN_3hUlVotISs6XAKxrdzIu3g
contact@vshp.org
tel: 850-728-4474
fax: 678-401-0259